Literature DB >> 2140904

Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat.

M Briley1, P Chopin, C Moret.   

Abstract

5,7-Dihydroxytryptamine (250 micrograms) was administered intracerebroventricularly to rats to lesion central serotonergic neurones. Fourteen days later the rats were tested in the elevated plus-maze "anxiety" model in comparison to sham lesioned animals. Twenty-four hours later, the rats were killed and serotonin levels and [3H]paroxetine binding measured in cortical and hippocampal membranes. The lesion destroyed 81% of the serotonergic innervation in the cortex and 99% in the hippocampus as determined by endogenous serotonin levels. Lesioned rats had an increased ratio of open/total arm entries in the elevated plus-maze, reflecting a decreased level of "anxiety". These results are compatible with the implication of serotonin in the control of anxiety and suggest that an anxiolytic effect may be induced by lowering the level of serotonergic activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140904     DOI: 10.1007/bf02244124

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  5-Hydroxytryptamine and punishment.

Authors:  N C Tye; B J Everitt; S D Iversen
Journal:  Nature       Date:  1977-08-25       Impact factor: 49.962

2.  The effects of benzodiazepines and serotonergic manipulations on punished responding.

Authors:  N C Tye; S D Iversen; A R Green
Journal:  Neuropharmacology       Date:  1979 Aug-Sep       Impact factor: 5.250

3.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone.

Authors:  M Carli; C Prontera; R Samanin
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

5.  Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat.

Authors:  M H Thiébot; P Soubrié; M Hamon; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

7.  Attenuation of induced-anxiety in rats by chlordiazepoxide: role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons.

Authors:  M H Thiébot; M Hamon; P Soubríe
Journal:  Neuroscience       Date:  1982       Impact factor: 3.590

8.  Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.

Authors:  C D Wise; B D Berger; L Stein
Journal:  Science       Date:  1972-07-14       Impact factor: 47.728

9.  L-5-hydroxytryptophan in the treatment of anxiety disorders.

Authors:  R S Kahn; H G Westenberg
Journal:  J Affect Disord       Date:  1985 Mar-Apr       Impact factor: 4.839

10.  Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.

Authors:  C T Fischette; B Nock; K Renner
Journal:  Brain Res       Date:  1987-09-22       Impact factor: 3.252

View more
  15 in total

1.  On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA.

Authors:  A Richard Green; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2002-08       Impact factor: 4.530

Review 2.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

3.  Serotonin-specific lesions of the dorsal raphe disrupt maternal aggression and caregiving in postpartum rats.

Authors:  M Allie Holschbach; Erika M Vitale; Joseph S Lonstein
Journal:  Behav Brain Res       Date:  2018-04-10       Impact factor: 3.332

4.  Hyperfunction of muscarinic receptor maintains long-term memory in 5-HT4 receptor knock-out mice.

Authors:  Luis Segu; Marie-José Lecomte; Mathieu Wolff; Julie Santamaria; René Hen; Aline Dumuis; Sylvie Berrard; Joël Bockaert; Marie-Christine Buhot; Valérie Compan
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

5.  Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.

Authors:  Q David Walker; Christina N Williams; Rakesh P Jotwani; Samuel T Waller; Reynold Francis; Cynthia M Kuhn
Journal:  Psychopharmacology (Berl)       Date:  2006-09-23       Impact factor: 4.530

6.  Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation.

Authors:  Alexis R Howerton; Alison V Roland; Tracy L Bale
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

7.  Neonatal serotonin depletion alters behavioral responses to spatial change and novelty.

Authors:  Christine F Hohmann; Ellen M Walker; Carolyn B Boylan; Mary E Blue
Journal:  Brain Res       Date:  2007-01-17       Impact factor: 3.252

8.  Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions.

Authors:  M A Critchley; K Njung'e; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Differential postpartum sensitivity to the anxiety-modulating effects of offspring contact is associated with innate anxiety and brainstem levels of dopamine beta-hydroxylase in female laboratory rats.

Authors:  C M Ragan; J S Lonstein
Journal:  Neuroscience       Date:  2013-10-22       Impact factor: 3.590

10.  Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission.

Authors:  Katie A Jennings; Merewyn K Loder; W John Sheward; Qi Pei; Robert M J Deacon; Matthew A Benson; Henry J Olverman; Nicholas D Hastie; Anthony J Harmar; Sanbing Shen; Trevor Sharp
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.